Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Carfilzomib for HLA Desensitization in Kidney Transplant Candidates
NCT02442648Phase 1Unknown
- Start
- Dec 2014
- Primary completion
- Jun 2021
- Modality
- Irreversible Covalent Inhibitors, Reversible Covalent Inhibitors
- Countries
- 1
01
Overview
Phase 1, open-label trial of carfilzomib in Human Leukocyte Antigen Sensitization. Status: unknown.
02
Drugs
carfilzomib
03
Conditions
Human Leukocyte Antigen Sensitization
Beyond the preview
Go deeper on NCT02442648.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02442648.